Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes. Issue 1 (24th January 2022) - Reverté, Laia; Yeregui, Elena; Olona, Montserrat; Gutiérrez‐Valencia, Alicia; Buzón, Maria José; Martí, Anna; Gómez‐Bertomeu, Frederic; Auguet, Teresa; López‐Cortés, Luis F.; Burgos, Joaquin; Benavent‐Bofill, Clara; Boqué, Carme; et al.